18.7 C
Munich
Monday, July 8, 2024
- Advertisement -
- Advertisement -spot_img

TAG

arimoclomol

Orphazyme pronounces withdrawal of European Advertising Authorisation Utility for arimoclomol for the therapy of Niemann-Choose illness kind C

Orphazyme A/S Firm announcement No. 13/2022 Inside infowww.orphazyme.com Firm Registration No. 32266355   Choice to withdraw the European Advertising Authorisation Utility comes forward of scheduled ultimate vote on the...

Latest news

- Advertisement -spot_img